Videoscopic Ilioinguinal Lymphadenectomy for Melanoma
NCT02508909 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 23
Last updated 2015-07-27
Summary
Groin lymph node dissection for melanoma patients is burdened by high post-operative morbidity, mainly related to wound. This is a prospective pilot trial investigated feasibility and postoperative outcomes of videoscopic ilioinguinal lymphadenectomy in patients with inguinal lymph node melanoma metastases.
Conditions
- Melanoma
- Secondary Malignant Neoplasm of Lymph Node
Interventions
- PROCEDURE
-
Videoscopic ilioinguinal dissection
Inguinal dissection is performed after subcutaneous inflation via three ports. Iliac dissection is obtained through a pro-peritoneal access.
Sponsors & Collaborators
-
Istituto Oncologico Veneto IRCCS
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-09-30
- Primary Completion
- 2015-01-31
- Completion
- 2015-01-31
More Related Trials
-
Early Complications After Axillary and Inguinal Lymph Node Dissection in Stage III Melanoma Patients
NCT04680182 ·Status: COMPLETED ·Phase: NA
-
Cryoablation+Ipilimumab+Nivolumab in Melanoma
NCT05779423 ·Status: RECRUITING ·Phase: PHASE2
-
Intravital Microscopy in Identifying Tumor Vessels in Patients With Stage IB-IIIC Melanoma Undergoing Sentinel Lymph Node Biopsy
NCT02857374 ·Status: COMPLETED ·Phase: NA
-
Neoadjuvant L19IL2/L19TNF- Pivotal Study
NCT02938299 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Omitting Therapeutic Lymph Node Dissection in Patients With Melanoma (Stage 3) and Major Pathological Response in the Index Lymph Node
NCT06754904 ·Status: RECRUITING ·Phase: NA
-
Cryoablation Combined With Tislelizumab Plus Lenvatinib in Patients With Melanoma Liver Metastasis
NCT05406466 ·Status: UNKNOWN ·Phase: PHASE2
-
Comparing SLNE With or Without Preoperative Hybrid SPECT/CT in Melanoma
NCT03683550 ·Status: UNKNOWN ·Phase: NA
-
Multicenter Selective Lymphadenectomy Trial (MSLT)
NCT00275496 ·Status: COMPLETED ·Phase: PHASE3
-
Safety of UV1 Vaccination in Combination With Ipilimumab in Patients With Unresectable or Metastatic Malignant Melanoma
NCT02275416 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Randomized Phase III Study of Management of Treatment Naive Primary Melanoma in Elderly Patients
NCT07068074 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Pilot Study Evaluating the Efficacy and Safety of Metformin in Melanoma
NCT01840007 ·Status: COMPLETED ·Phase: PHASE2
-
SWOG-9430: Surgery in Treating Patients With Metastatic Melanoma
NCT00002860 ·Status: COMPLETED ·Phase: PHASE2
-
Study of the Combination of Lenalidomide and DTIC (Dacarbazine) in Patients With Metastatic Malignant Melanoma Previously Untreated With Systemic Chemotherapy
NCT00179608 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluating the Use of Fibrin Tissue Adhesive in Melanoma Patients
NCT00506311 ·Status: COMPLETED ·Phase: NA
-
A Trial Evaluating the Safety & Efficacy of Intra-Tumoral Ipilimumab in Combination With Intra-venous Nivolumab in Patients With Metastatic Melanoma
NCT02857569 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Phase I/II Dose Escalation Study of the Tumor-targeting Human L19-IL2 Monoclonal Antibody-cytokine Fusion Protein in Combination With Dacarbazine for Patients With Metastatic Melanoma
NCT02076646 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
High-resolution Magnetic Resonance Imaging (MRI) Scans to Look for Spread of Melanoma to Nearby Lymph Nodes
NCT00463892 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Compare the Efficacy and Safety of CC-5013 vs. Placebo in Subjects With Metastatic Malignant Melanoma.
NCT00057616 ·Status: COMPLETED ·Phase: PHASE3
-
Interferon Alfa-2b in Treating Patients With Melanoma and Early Lymph Node Metastasis
NCT00004196 ·Status: COMPLETED ·Phase: PHASE3
-
Pilot Study of Infrared Imaging of Cutaneous Melanoma
NCT00937690 ·Status: COMPLETED
-
Multicenter Selective Lymphadenectomy Trial II (MSLT-II)
NCT00297895 ·Status: COMPLETED ·Phase: NA
-
The Multicentre Selective Lymphadenectomy Trial - 3
NCT07049276 ·Status: RECRUITING ·Phase: NA
-
Phase I/II Study of Chemo-Immunotherapy Combination in Melanoma Patients
NCT00559026 ·Status: COMPLETED ·Phase: PHASE1
-
Identification of Metabolic Phenotypes Associated With Melanoma Metastasis
NCT06400550 ·Status: RECRUITING
-
Intravital Microscopy for Identifying Tumor Vessels in Patients With Stage IA-IV Melanoma That is Being Removed by Surgery
NCT01886235 ·Status: COMPLETED ·Phase: NA